Global Assets Advisory LLC Has $395,000 Holdings in CME Group Inc. $CME

Global Assets Advisory LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 49.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,435 shares of the financial services provider’s stock after selling 1,396 shares during the period. Global Assets Advisory LLC’s holdings in CME Group were worth $395,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Webster Bank N. A. increased its holdings in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC grew its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 43 shares in the last quarter. Wayfinding Financial LLC bought a new position in shares of CME Group in the first quarter worth $25,000. Cornerstone Planning Group LLC raised its position in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its stake in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Price Performance

CME opened at $262.05 on Tuesday. The firm has a 50-day moving average price of $269.74 and a 200-day moving average price of $271.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a market capitalization of $94.44 billion, a price-to-earnings ratio of 25.37, a PEG ratio of 5.57 and a beta of 0.41.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the business earned $2.56 earnings per share. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is 48.40%.

Insider Buying and Selling

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock valued at $3,527,956 over the last quarter. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on CME shares. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a report on Saturday, September 27th. Morgan Stanley increased their price objective on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 1st. Barclays set a $298.00 target price on CME Group and gave the stock an “equal weight” rating in a report on Thursday, July 24th. Oppenheimer increased their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Finally, UBS Group lowered their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a report on Monday, September 8th. Six research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $274.15.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.